Efficacy and effectiveness of pneumococcal polysaccharide vaccines and their use in industrialised countries

Medical Journal of Australia

Volumn 173, Issue SUPPL. OCT., 2000, Pages

  Lehmann, D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOCOCCUS VACCINE;

ADOLESCENT; ADULT; CHILD; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INDUSTRIALIZATION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; REVIEW; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE ACTIVATION; VACCINATION;

EID: 0034597004     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2000.tb139413.x     Document Type: Review

References (30)

1. Antibiotic resistance in Streptococcus pneumoniae
2. Conjugate pneumococcal vaccines: An overview
3. Conjugate pneumococcal vaccines for Aboriginal children in Australia
4. Conjugate pneumococcal vaccines for non-Indigenous children in Australia
5. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides
6. Prevention of pneumococcal pneumonia by vaccination
7. Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community
8. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study
9. Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions
10. Clinical efficacy of pneumococcal vaccine in the elderly: A randomized, single-blind population-based trial
11. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
12. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study
13. Pneumococcal vaccine after 15 years of use. Another view
14. Inefficacy of pneumococcal vaccine in a high-risk population
15. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine
16. The clinical effectiveness of pneumococcal vaccine in the elderly
17. Epidemiology of invasive pneumococcal disease
18. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations
19. Potential interventions for the prevention of childhood pneumonia: Geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children - Implications for vaccine strategies
20. Vaccination against Streptococcus pneumoniae in childhood: Lack of demonstrable benefit in young Australian children
21. Pneumococcal vaccine and odds media
22. Effect of pneumococcal vaccine on morbidity from acute lower respiratory tract infections in Papua New Guinean children
23. Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children
24. Pneumococcal polysaccharide vaccine effectiveness among children of ages 2 through 5
25. IgG antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea
26. Pneumococcal vaccine
27. Pneumococcal vaccination: An important strategy to prevent pneumonia in Aboriginal and Tortes Strait Island adults
28. Invasive pneumococcal disease in central Australia
29. Invasive pneumococcal disease in central Australia